Colorectal Testing Utilization and Payments in a Large Cohort of Commercially Insured US Adults

OBJECTIVES:Screening decreases colorectal cancer (CRC) mortality. The national press has scrutinized colonoscopy charges. Little systematic evidence exists on colorectal testing and payments among commercially insured persons. Our aim was to characterize outpatient colorectal testing utilization and payments among commercially insured US adults.METHODS:We conducted an observational cohort study of outpatient colorectal test utilization rates, indications, and payments among 21 million 18–64-year-old employees and dependants with noncapitated group health insurance provided by 160 self-insured employers in the 2009 Truven MarketScan Databases.RESULTS:Colonoscopy was the predominant colorectal test. Among 50–64-year olds, 12% underwent colonoscopy in 1 year. Most fecal tests and colonoscopies were associated with screening/surveillance indications. Testing rates were higher in women, and increased with age. Mean payments for fecal occult blood and immunochemical tests were $5 and $21, respectively. Colonoscopy payments varied between and within sites of service. Mean payments for diagnostic colonoscopy in an office, outpatient hospital facility, and ambulatory surgical center were $586 (s.d. $259), $1,400 (s.d. $681), and $1,074 (s.d. $549), respectively. Anesthesia and pathology services accompanied 35 and 52% of colonoscopies, with mean payments of $494 (s.d. $354) and $272 (s.d. $284), respectively. Mean payments for the most prevalent colonoscopy codes were 1.4- to 1.9-fold the average Medicare payments.CONCLUSIONS:Most outpatient colorectal testing among commercially insured adults was associated with screening or surveillance. Payments varied widely across sites of service, and payments for anesthesia and pathology services contributed substantially to total payments. Cost-effectiveness analyses of CRC screening have relied on Medicare payments as proxies for costs, but cost-effectiveness may differ when analyzed from the perspectives of Medicare or commercial insurers.

[1]  Nancy Breen,et al.  Progress in cancer screening practices in the United States , 2003, Cancer.

[2]  S. Tomar,et al.  Surveillance for use of preventive health-care services by older adults, 1995-1997. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[3]  Michael Pignone,et al.  Cost-Effectiveness Analyses of Colorectal Cancer Screening , 2002, Annals of Internal Medicine.

[4]  U. Ladabaum,et al.  Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. , 2005, Gastroenterology.

[5]  U. Ladabaum,et al.  Colorectal cancer screening differential costs for younger versus older Americans. , 2006, American journal of preventive medicine.

[6]  T. Stukel,et al.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  James C. Robinson,et al.  Payers test reference pricing and centers of excellence to steer patients to low-price and high-quality providers. , 2012, Health affairs.

[8]  C. Klabunde,et al.  Trends in colorectal cancer test use in the medicare population, 1998-2005. , 2009, American journal of preventive medicine.

[9]  D. Cutler,et al.  Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data. , 2013, Statistical journal of the IAOS.

[10]  A. Sonnenberg,et al.  Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. , 2008, Gastrointestinal endoscopy.

[11]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[12]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[13]  J. Burkhardt,et al.  Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. , 2006, Preventive medicine.

[14]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[15]  A. Zauber,et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.

[16]  H. Brenner,et al.  Protection From Colorectal Cancer After Colonoscopy , 2011, Annals of Internal Medicine.

[17]  Nancy Breen,et al.  Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  Tzuyung D Kou,et al.  Complications following colonoscopy with anesthesia assistance: a population-based analysis. , 2013, JAMA internal medicine.

[19]  A. Neugut,et al.  Colonoscopy vs sigmoidoscopy screening: getting it right. , 2010, JAMA.

[20]  L M Schuman,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[21]  Á. Lanas,et al.  Vorsorge des kolorektalen Karzinoms: Koloskopie oder immunologischer Stuhltest , 2013, Zeitschrift für Gastroenterologie.

[22]  P. Franks,et al.  Persistent Racial and Ethnic Disparities in Up‐to‐Date Colorectal Cancer Testing in Medicare Enrollees , 2009, Journal of the American Geriatrics Society.

[23]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[24]  W. Kreuter,et al.  Regional variation in anesthesia assistance during outpatient colonoscopy is not associated with differences in polyp detection or complication rates. , 2013, Gastroenterology.

[25]  S. Mattke,et al.  Utilization of anesthesia services during outpatient endoscopies and colonoscopies and associated spending in 2003-2009. , 2012, JAMA.

[26]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[27]  C. Reynolds,et al.  US Preventive Services Task Force Recommendation Statement on Screening for Depression in Adults: Not Good Enough. , 2016, JAMA psychiatry.

[28]  H. Brenner,et al.  Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. , 2010, Journal of the National Cancer Institute.

[29]  L. Bisanti,et al.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. , 2011, Journal of the National Cancer Institute.

[30]  Mary C. White,et al.  Cancer screening - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[31]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[32]  M. Kaminski,et al.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy , 2013 .

[33]  David M. Adamson,et al.  HealtH ReseaRcH Data foR tHe Real WoRlD: tHe MaRketscan ® Databases , 2008 .

[34]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[35]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[36]  Ahmedin Jemal,et al.  Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[37]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[38]  S. Ketover.  Bundled payment for colonoscopy. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  Trends in screening for colorectal cancer--United States, 1997 and 1999. , 2001, MMWR. Morbidity and mortality weekly report.

[40]  Screening for colorectal cancer--United States, 1992-1993, and new guidelines. , 1996, MMWR. Morbidity and mortality weekly report.

[41]  D. Lieberman,et al.  Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[43]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[44]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[45]  U. Ladabaum,et al.  Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies , 2013, The American Journal of Gastroenterology.

[46]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[47]  J. Habbema,et al.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. , 2009, Journal of the National Cancer Institute.

[48]  U. Ladabaum,et al.  Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. , 2012, Gastroenterology.

[49]  L. Seeff,et al.  Increase in Screening for Colorectal Cancer in Older Americans: Results from a National Survey , 2008, Journal of the American Geriatrics Society.

[50]  Karla Kerlikowske,et al.  Trends in Colonoscopy for Colorectal Cancer Screening , 2007, Medical care.